Industries de la santé
02 Octobre 2013
Bone Therapeutics’ allogeneic osteoblastic product to enter clinic for the treatment of delayed union fractures |Gosselies, Belgium, 1st October 2013 - BONE THERAPEUTICS, the leading biopharmaceutical company focused on innovative cell therapy products for the treatment of bone diseases, announces today that it has received clearance from the Competent Authorities in Belgium and the UK...
Plus d'articles...
- Antiepileptic Drug Use While Pregnant Impacts Early Child Development
- Colorectal Cancer Survivors Face Increased Risk of Developing Subsequent Cancers of Different Types
- BASF, Cargill and Novozymes achieve milestone in bio-based acrylic acid process - Success in producing 3-hydroxypropionic acid for bio-based acrylic acid
- Alzheimer’s disease protein controls movement in mice